Thibaut Mongon, Exec VP, WW Chair, Cons Health at Johnson & Johnson, holds 112.20K shares in Kenvue, Inc. (Ticker: KVUE), holds 65.92K shares in Johnson & Johnson (Ticker: JNJ).

See the Hottest Stocks Based on Insider Trading >

Thibaut Mongon
Johnson & Johnson (JNJ)
Exec VP, WW Chair, Cons Health

Ranked #54,304 out of 98,743 Corporate Insiders

Profitable Transactions

2 out of 3 Profitable Transactions

Average Return

-3.50%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

81.31%

JNJ

18.69%

KVUE

A breakdown of Thibaut Mongon's holdings

See the Top Stocks by Insiders

Insider Roles

Johnson & Johnson
(JNJ)

Exec VP, WW Chair, Cons Health

Kenvue, Inc.
(KVUE)

CEO, Director

Roles that Thibaut Mongon holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Johnson & Johnson
(JNJ)

Rating:Informative Sell

Date:Nov 08, 2022 - Nov 08, 2023

Return:+0.70%

The most profitable trade made by Thibaut Mongon

See the Latest Stocks Traded by Insiders

Thibaut Mongon's Trading History

JNJ

Johnson & Johnson

Feb 15, 2023

Exec VP, WW Chair, Cons Health

Uninformative Buy

―

$9.80M

KVUE

Kenvue, Inc.

Feb 15, 2024

CEO, Director

Uninformative Buy

83.49K

$2.25M

List of latest transactions for each holding click on a transaction to see Thibaut Mongon's performance on stock

See All Insider Trading from Today

Thibaut Mongon insider profile FAQ

What is the percentage of profitable transactions made by Thibaut Mongon?

The percentage of profitable transactions made by Thibaut Mongon is 67%.

What is the average return per transaction made by Thibaut Mongon?

The average return per transaction made by Thibaut Mongon is -3.50%.

What stocks does Thibaut Mongon hold?

Thibaut Mongon holds: JNJ, KVUE stocks.

What was Thibaut Mongon’s latest transaction?

Thibaut Mongon latest transaction was an Uninformative Buy of $83.49K.

What was Thibaut Mongon's most profitable transaction?

Thibaut Mongon’s most profitable transaction was an Informative Sell of JNJ stock on November 8, 2022. The return on the trade was 0.70%.

What is Thibaut Mongon's role in Johnson & Johnson?

Thibaut Mongon's role in Johnson & Johnson is Exec VP, WW Chair, Cons Health.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Thibaut Mongon Insider Profile

Thibaut Mongon Johnson & Johnson (JNJ)Exec VP, WW Chair, Cons Health